MetLife, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

MetLife stock costs EUR 88.45 as November 4 results near

Dividend Earnings report Share buyback AI-generated analysis

πŸ“ˆ MetLife reported adjusted earnings of USD 1.6 billion in Q2 2026, a 15% increase year over year.

πŸš€ Group Benefits segment generated USD 503 million in adjusted earnings, up 25% from the prior year.

🌏 Asia region earnings reached USD 420 million, marking a 21% year-over-year growth.

πŸ’° MetLife repurchased approximately USD 700 million of common shares in the second quarter.

πŸ“œ The company announced a new authorization for up to USD 3 billion in share repurchases.

πŸ’Έ A fourth-quarter dividend of USD 0.5925 per share was declared, payable on December 8, 2026.

🏦 JPMorgan raised its price target from USD 108.00 to USD 110.00 with an overweight rating.

πŸ“Š Assets under management reached USD 748 billion as of June 30, 2026.

πŸ—“οΈ Third-quarter results are scheduled for release on November 4, 2026, after market close.

πŸ“ž The earnings call is set to take place on November 5, 2026.

Bullish Signals
  • MetLife reported adjusted earnings of USD 1.6 billion in the second quarter of 2026, representing a significant 15% year-over-year increase.
  • The Group Benefits segment generated USD 503 million in adjusted earnings, up 25% from the prior year period.
  • Asia region earnings reached USD 420 million, showing strong growth of 21% compared to the previous year.
  • MetLife repurchased approximately USD 700 million of common shares in the second quarter and announced a new USD 3 billion repurchase authorization.
  • JPMorgan raised its price target from USD 108.00 to USD 110.00 while maintaining an overweight rating on the stock.
  • Assets under management grew to reach USD 748 billion as of June 30, 2026, indicating strong investment performance.
  • Adjusted earnings per share rose 20% to USD 2.43, and adjusted return on equity reached 17% in the second quarter.
Full Analysis
MetLife Inc. is preparing to release its third-quarter 2026 earnings results on November 4, following a strong second quarter where the company reported adjusted earnings of USD 1.6 billion, representing a 15% year-over-year increase. The insurer's performance was bolstered by significant growth in its Group Benefits segment, which generated USD 503 million in adjusted earnings up 25%, and its Asia region, which reached USD 420 million up 21%. Additionally, MetLife Investment Management reported USD 57 million in adjusted earnings, contributing to total assets under management reaching USD 748 billion as of June 30, 2026. Beyond operational growth, MetLife executed a robust capital return strategy during the second quarter by repurchasing approximately USD 700 million of common shares and announcing a new authorization for up to USD 3 billion in share repurchases. The company also declared a fourth-quarter dividend of USD 0.5925 per share, payable on December 8, 2026, to shareholders of record on November 3. Analyst sentiment remains positive, with JPMorgan raising its price target from USD 108.00 to USD 110.00 while maintaining an overweight rating ahead of the upcoming earnings release. MetLife's stock is currently trading around EUR 88.45, though it has a primary listing on the NYSE where it quoted at USD 98.82 as of late October 2026. With a market capitalization of approximately USD 62.8 billion and a 52-week range between USD 67.33 and USD 103.65, investors are closely watching the November 4 report to determine if the momentum from the second quarter continues into the third quarter. The upcoming earnings call is scheduled for November 5, 2026.